Home/Pipeline/Bionanomatrix™ Vascular Access Gel

Bionanomatrix™ Vascular Access Gel

Arteriovenous Fistula (AVF) Maturation for Dialysis

Pre-clinicalActive

Key Facts

Indication
Arteriovenous Fistula (AVF) Maturation for Dialysis
Phase
Pre-clinical
Status
Active
Company

About Endomimetics

Endomimetics is a private, pre-revenue biotech company pioneering a nanotechnology platform called Bionanomatrix™. This platform utilizes peptide-based coatings and gels that release nitric oxide and other agents to improve healing, reduce complications like infection and thrombosis, and enhance the integration and longevity of medical implants. With applications spanning cardiovascular, orthopedic, and dental fields, the company aims to address significant unmet needs in surgical and implant outcomes through strategic partnerships and future commercialization.

View full company profile